There's no question that Liberty Health Sciences and Aphria have a close connection. At one point, Aphria owned a sizable stake in Liberty before divesting its interest in the company to maintain its listing on the Toronto Stock Exchange (TSX). This move was taken because Liberty has significant operations in the U.S., and the TSX doesn't allow cannabis companies listed on the exchange to have operations in jurisdictions where marijuana is illegal at the federal level.
Aphria CEO Vic Neufeld, though, continues to serve as chairman of the board of directors for Liberty Health Sciences. John Cervini, who co-founded Aphria and is co-chairman of the company's board, is also a director on Liberty's board.
Liberty CEO George Scorsis acknowledged in a phone interview that his company "started off as Aphria's little baby," adding that "unfortunately some of that view still exists." He maintained that Liberty's board acts independently from Aphria.
Scorsis himself previously served as chairman of the board for Scythian Biosciences, now known as SOL Global Investments. Aphria acquired LATAM Holdings from SOL, the transaction that short-sellers alleged was overpriced and helped line the pockets of insiders with Aphria. However, Scorsis stated that he resigned from Scythian's board several months ago, prior to the closing of the LATAM Holdings transaction with Aphria, to focus solely on Liberty Health Sciences.
Behind the Liberty controversy The initial report about alleged improprieties with Aphria's acquisition of LATAM Holdings didn't refer to Liberty Health Sciences. However, the follow-up report from Hindenburg Research brought Liberty into the Aphria controversy.
Hindenburg Research alleged that Liberty paid 13.5 million in Canadian dollars earlier this year for real estate from a private shell entity controlled by current SOL Global Investments chairman Andy DeFrancesco. The short-seller stated that DeFrancesco's shell company had purchased the Florida property only six days earlier for CA$8.5 million.
The report also insinuated that Aphria allowed Vic Neufeld to buy shares of Liberty Health Sciences "at a 99.5% discount." This was in reference to details surrounding Aphria's backing of Liberty Health Sciences becoming a public entity via a reverse merger in 2017.
Liberty Health Sciences issued a statement on Dec. 6, 2018, that said Hindenburg Research's report contained "a number of factual errors and outdated information." The statement added that Liberty "takes the unconfirmed allegations contained in the report very seriously and will provide updates as they relate to this matter in due course."
Beyond the controversy It's important to remember that Hindenburg Research profits if Aphria stock falls. The short-seller has a financial interest in spinning anything involving Aphria in the worst light possible. And that includes the connections between Aphria and its executives and Liberty Health Sciences.
Even more important, though, is the fact that none of the allegations reflect negatively on Liberty's long-term prospects. Actually, Liberty announced some encouraging news about its prospects on Friday -- the day after Hindenburg Research's report referencing the company was published.
Liberty reported sales for the quarter ending Nov. 30, 2018, of 3.2 million in Canadian dollars, up 45% from the previous sequential quarter. The company's patient count jumped 46% during the last quarter to around 14,500 patients.
More strong growth appears likely. Liberty opened three new dispensaries in Florida during the last quarter. That brings the company's total number of dispensaries in the state to seven. But Liberty expects to double that number by the end of February 2019, pending approvals from the Florida Department of Health.
The company also provided an update on the construction of its 225,000-square-foot Liberty 360 medical cannabis production facility. Liberty anticipates completing construction in 2019. The company currently uses 20,000 square feet of the property for the cultivation of cannabis and has another 24,000 square feet at its Alachua property. By early 2019, Liberty will add 80,000 square feet as the next phase of construction at Liberty 360 wraps up.
In addition, Liberty said that it expects to open its Dayton, Ohio, medical cannabis dispensary with joint venture partner the Schottenstein Group by the end of March 2019. A 10,000-square-foot processing facility for extraction, refining, formulation, and packaging medical cannabis products is scheduled to open in spring 2019, pending necessary regulatory approvals.
A beaten-down bargain? The short-seller reports have caused Liberty Health Sciences' share price to sink more than 30% over the last few days. In my view, the sell-off has been overdone -- especially considering that Liberty itself hasn't been accused of any wrongdoing. The good news, though, is that it makes Liberty an attractive bargain for aggressive investors.
Liberty appears to be making steady progress in Florida. Arcview Market Research and BDS Analytics project the state's medical marijuana market will top $1.7 billion by 2022. Liberty Health Sciences thinks it currently claims a 15% market share. With new dispensaries and significantly greater production capacity on the way, the company could boost that share considerably.
Thanks to this past week's negative headlines, Liberty's market cap is only around $230 million. I think that all the company needs to do is stay the course with its efforts in Florida and Ohio to be worth a lot more over the next few years.
Keith Speights has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
HMLSF looking at the one year chart, I can see why buy and hold can be a terrifying option. Swing trading, rolling or trading around a position would work but how many individual investors are up to the task?
ACB Aurora Cannabis Inc. 37,345 4 minutes ago Cannabis Cannabis Investment Club 778 4 minutes ago Industry USMJ North American Cannabis Holdings Inc. 79,386 55 minutes ago KNHBF ICC Intl Cannabis Corp. 214 1 hour ago Cannabis GCAN Greater Cannabis Company Inc. 10,898 1 hour ago Cannabis SPRWF Supreme Cannabis Co Inc. 27,768 2 hours ago Medical - SCNA Smart Cannabis Corp. 8,948 3 hours ago Cannabis LIHTF Liht Cannabis Corp. 2,074 3 hours ago Cannabis TCNNF Trulieve Cannabis Corp 1,204 4 hours ago Cannabis HRVOF Harvest One Cannabis, Inc 39 4 hours ago Cannabis CBDS Cannabis Sativa Inc. 4,553 4 hours ago Cannabis CBWTF Auxly Cannabis Group Inc. 2,105 5 hours ago Cannabis FNNZF FinCanna Capital Corp. (FNNZF) / Medical Cannabi 125 CAPTAINSCOTTY''S CANNABIS COALITION 1,834 9 hours ago Support F Cannabis and Hemp Sector Ideas 231 9 hours ago User's Groups CBIS Cannabis Science, Inc. 128,481 10 hours ago C REFG Medical Cannabis Payment Solutions 2,120 11 hours ago CCAN Canadian Cannabis Corp. 368 12 hours ago Cannabis IGPK Integrated Cannabis Solutions Inc. 3,062 1 day ago C Cannabis - Oils and CBD 29 2 days ago Support Forums NUGS Cannabis Strategic Ventures 11,476 2 days ago Cannabis TSXV:EMC Emblem Cannabis 601 2 days ago Cannabis Cannabis Best Opportunity Stocks $0.10 to $0.75 87 3 days ago I Cannabis U.S. Companies 1,874 3 days ago User's Groups NCNNF 48North Cannabis Corp. 0 3 days ago Cannabis VVCIF Vivo Cannabis Inc. 993 3 days ago Cannabis CNAB United Cannabis Corp. 5,710 3 days ago Cannabis NACNF National Access Cannabis Corp 27 5 days ago Cannabis HSTRF BlissCo Cannabis Company 102 5 days ago Cannabis VRNDF Delta 9 Cannabis Inc. 435 5 days ago Cannabis CANN General Cannabis Corp. 11,546 5 days ago Cannabis NRTH 48North Cannabis Company 26 6 days ago Cannabis AMMJ American Cannabis Company Inc. 13,998 6 days ago Cannabis HTHHF Cannabis 1 6 days ago Cannabis CBAQF Cannabis Strategies Acquisition Corp 30 7 days ago C HERTF Heritage Cannabis Holdings Corp. 133 7 days ago C FUAPF Global Cannabis Applications Corp. 206 8 days ago C Cannabis IPO Watch CA and US 210 14 days ago Health and Sc ICNAF Integrated Cannabis Company Inc. 299 15 days ago M TSXV:FIRE The Supreme Cannabis Company, Inc. 47 15 days Cannabis Pharmaceuticals 25 1 month ago User's Groups PRCNF Pure Global Cannabis Inc. 48 1 month ago Cannabis Cannabis Stock Plays 503 1 month ago User's Groups TSXV:ICC International Cannabis Corporation 52 1 month CNSX:LOAN The Cannabis Merchants Bank: Redfund Cap Corp 25 Cannabis Canadian and U. S. Priced At $0.01 to $0. 644 2 mont ACB Aurora Cannabis 172 2 months ago Cannabis TSXV:NAC National Access Cannabis 27 3 months ago Redfund CAp Corp - The Cannabis Merchants Bank 4 3 months ago TSXV:XLY Auxly Cannabis 22 3 months ago Cannabis HUGE CNX Top Cannabis Newcomer! 0 5 months ago 3 SPBBF Speakeasy Cannabis Club Ltd. 19 6 months ago C TSXV:CBW Cannabis Wheaton Income Corp. 263 6 months ago CWWBF Cannabis Growth Opportunity Corp 1 6 months ago Speak SpeakEasy Cannabis 0 7 months ago Cannabis EASY SpeakEasy Cannabis Club 0 7 months ago Cannabis CNSX:APP Global Cannabis Applications Corp 8 7 mon Cannavestor - Cannabis Investments 331 9 months ago I Cannabis Industry Coin (XCIUSD) 0 10 months ago Coins CannabisCoin (CANNUSD) 0 10 months ago Coins TSXV:CBW.WT Cannabis Wheaton Corp 4 12 months ago C Invest in Cannabis 21 1 year ago Industry Specific Cannabis Investor Group 3 1 year ago Industry Specific TSV:ACB Aurora Cannabis Inc. 2 1 year ago Cannabis TSXV:ICC Icc International Cannabis 1 1 year ago C South American Coal and Cannabis 2 1 year ago User's G Bedrocan Cannabis Co. (fka BNRDF) 39 3 years ago Delisted TSXV:BED Bedrocan Cannabis Corp. 875 3 years ago Medical - Risks of Cannabis stocks 0 4 years ago Industry Specific BNRDF BEDROCAN CANNABIS CO 29 4 years ago Cannabis South Florida Cannabis Traders 5 5 years ago User's Groups C2J Cannabis Medical Solutions Inc. 4 7 years ago Foreign S